TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive Wyngaarden Recommendation On New Director Due Nov. 1o; Five Staff Members Nominated November 4, 1988
TCL Archive NCI Supercomputer Upgrading Supported By DCBD Board; Could Cost $40 Million Plus Renovations March 3, 1989
